References
- DoucetOLanvinMThillouCReconstituted human corneal epithelium: a new alternative to the Draize eye test for the assessment of the eye irritation potential of chemicals and cosmetic productsToxicol In Vitro20062049951216243479
- Van GoethemFAdriaensEAlepeeNPrevalidation of a new in vitro reconstituted human cornea model to assess the eye irritating potential of chemicalsToxicol In Vitro20062011716019187
- PaulyAMeloniMBrignole-BaudouinFWarnetJMBaudouinCMultiple endpoint analysis of the 3D-reconstituted corneal epithelium after treatment with benzalkonium chloride: early detection of toxic damageInvest Ophthalmol Vis Sci2009501644165219168896
- MeloniMPaulyADe ServiBLe VarletBBaudouinCOccludin gene expression as an early in vitro sign for mild eye irritation assessmentToxicol In Vitro20102427628519729060
- MeloniMDalla VallePCappadoroMDe WeverBThe importance of multiple endpoint analysis (MEA) using reconstituted human tissue models for irritation and biocompatibility assayInvitox Abstract Book200247
- McCarthyKMSkareIBStankewichMCOccludin is a functional component of the tight junctionJ Cell Sci1996109Pt 9228722988886979
- MatterKBaldaMSEpithelial tight junctions, gene expression and nucleo-junctional interplayJ Cell Sci2007120Pt 91505151117452622
- SchneebergerEELynchRDThe tight junction: a multifunctional complexAm J Physiol Cell Physiol2004286C1213C112815151915
- AjaniGSatoNMackJAMaytinEVCellular responses to disruption of the permeability barrier in a three-dimensional organotypic epidermal modelExp Cell Res20073133005301517512930
- BanYCooperLJFullwoodNJComparison of ultrastructure, tight junction-related protein expression and barrier function of human corneal epithelial cells cultivated on amniotic membrane with and without air-liftingExp Eye Res20037673574312742356
- BaudouinCHamardPLiangHConjunctival epithelial cell expression of interleukins and inflammatory markers in glaucoma patients treated over the long termOphthalmology20041112186219215582072
- TeraiNMüller-HolzMSpoerlEPillunatLEShort-term effect of topical antiglaucoma medication on tear-film stability, tear secretion, and corneal sensitivity in healthy subjectsClin Ophthalmol2011551752521573041
- InoueKFujimotoTHigaREfficacy and safety of a switch to latanoprost 0.005% + timolol maleate 0.5% fixed combination eyedrops from latanoprost 0.005% monotherapyClin Ophthalmol2012677177522693419
- CostaVPMoreiraHPaoleraMDde Moraes SilvaMRBEfficacy and safety of travoprost 0.004%/timolol 0.5% fixed combination as transition therapy in patients previously on prostaglandin analog monotherapyClin Ophthalmol2012669970622654495
- NakakuraSTabuchiHBabaYComparison of the latanoprost 0.005%/timolol 0.5% + brinzolamide 1% versus dorzolamide 1%/timolol 0.5% + latanoprost 0.005%: a 12-week, randomized open-label trialClin Ophthalmol2012636937522419858
- InoueKSetogawaAHigaRMoriyamaRWakakuraMTomitaGOcular hypotensive effect and safety of travoprost 0.004%/timolol maleate 0.5% fixed combination after change of treatment regimen from ß-blockers and prostaglandin analogsClin Ophthalmol2012623123522347794
- GadoASMackyTAFirst experience with BAK-free travoprost 0.004% in topical glaucoma medicationClin Ophthalmol201261422259229
- HommerAKimmichFSwitching patients from preserved prostaglandin-analog monotherapy to preservative-free tafluprostClin Ophthalmol2011562363121629567
- WirtaDVanDenburghAWengEWhitcupSKurstjensSBeddingfieldFLong-term safety evaluation of bimatoprost ophthalmic solution 0.03%: a pooled analysis of six double-masked, randomized, active-controlled clinical trialsClin Ophthalmol2011575976521691584
- De Saint JeanMBrignoleFBringuierAFEffects of benzalkonium chloride on growth and survival of Chang conjunctival cellsInvest Ophthalmol Vis Sci19994061963010067965
- NguyenDHBeuermanRWDeWeverBRosdyMThree dimensional construct of the human corneal epithelium for in vitro toxicologySalemHKatzSAlternative Toxicology MethodsBoca Raton, FLCRC Press2003
- PowersMJAmenuvorLRodinRDarnerJAn in vitro human corneal epithelial model for evaluation of ocular response to xenobiotic compoundsInvest Ophthalmol Vis Sci200748 Abstr 790
- MossmanTRapid colorimetric assay for cell growth and survival-application to proliferation and cytotoxicity assaysJ Immunol Methods19836555636606682